Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbidities.

Pembrolizumab as first line treatment of Merkel cell carcinoma patients - a case series of patients with various co-morbidities. Acta Oncol. 2020 Apr 14;:1-4 Authors: Bystrup Boyles T, Schødt M, Hendel HW, Krarup-Hansen A, Junker N PMID: 32285728 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32285728?dopt=Abstract

Source: Acta Oncologica - April 13, 2020 Category: Cancer & Oncology Authors: Bystrup Boyles T, Schødt M, Hendel HW, Krarup-Hansen A, Junker N Tags: Acta Oncol Source Type: research

More News: Cancer & Oncology | Carcinoma